Zobrazeno 1 - 10
of 1 347
pro vyhledávání: ''
Autor:
Atsushi Naganuma, Hiroaki Naruse, Yuki Tamura, Takeshi Hatanaka, Satoru Kakizaki, Keitaro Hirai, Hidetoshi Yasuoka, Takashi Hoshino, Yuhei Suzuki, Ichiro Sakamoto, Hiroshi Tanaka, Tetsushi Ogawa
Publikováno v:
Clinical Journal of Gastroenterology. 15:177-184
We herein report a successfully treated case of huge ruptured hepatocellular carcinoma (HCC) by conversion hepatectomy after transarterial embolization (TAE) and lenvatinib therapy. A 33-year-old male patient with right hypochondralgia and liver tumo
Autor:
Antoine Dufour, Raquel Farias, Leslie Cao, Mark R. Gillrie, Braedon McDonald, Bryan G. Yipp, Nicole L. Rosin, Angela P. Nguyen, Arzina Jaffer, Elodie Labit, Sarthak Sinha, Amy Bromley, Luiz Gustavo de Almeida, Jeff Biernaskie, Marvin J. Fritzler, Rohit Arora
Publikováno v:
Nature Reviews. Immunology
Nature Medicine
Nature Medicine
Although critical for host defense, innate immune cells are also pathologic drivers of acute respiratory distress syndrome (ARDS). Innate immune dynamics during Coronavirus Disease 2019 (COVID-19) ARDS, compared to ARDS from other respiratory pathoge
Autor:
Marianna Traugott, Erich Pawelka, Georg-Christian Funk, Michael Turner, Sara Omid, Boris Lindner, Alexander Zoufaly, Christoph Porpaczy, Sabine Publig, Christoph Wenisch, Tamara Seitz, Hasan Kelani, Mario Karolyi
Publikováno v:
Wiener klinische Wochenschrift. 133:1310-1317
BACKGROUND Diagnosis and treatment of influenza patients are often provided across several medical specialties. We compared patient outcomes at an infectious diseases (ID), a rheumatology (Rheu) and a pulmonology (Pul) department. MATERIAL AND METHOD
Autor:
Kenkichi Sugiura, Tohru Izumi, Takaaki Chou, Takuya Komeno, Makoto Sasaki, Shinichi Fukunaga, Yasuhito Terui, Deborah Berg, Takashi Ikeda, Shinsuke Iida
Publikováno v:
International Journal of Clinical Oncology
Background TOURMALINE-MM1 was a global study that demonstrated a significant improvement in progression-free survival with ixazomib plus lenalidomide and dexamethasone compared with placebo plus lenalidomide and dexamethasone, in patients with relaps
Autor:
Mei Zhao, Min Liu, Peng Zhao, Yi Huang, Shisi Huang, Shuangshuang Wen, Ying Chen, Bo Deng, Dan Ma, Yan Zhang, Ming Ni, Yan Li, Yun Zhan, Yanju Li, Xiao Chai, Fengqi Zhang, Qian Kang, Jishi Wang, Qin Fang
Publikováno v:
Annals of Hematology
This study aimed to evaluate the efficacy and safety of venetoclax plus azacitidine and donor lymphocyte infusion (DLI) in treating patients with relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSC
Autor:
Huanlin Wang, Noboru Harada, Kojiro Hata, Shinji Itoh, Katsuya Toshida, Tomonari Shimagaki, Tomoharu Yoshizumi, Hiroyuki Watanabe, Yoshihiro Nagao, Takeshi Kurihara, Yoko Makihara, Masaki Mori, Takeo Toshima
Publikováno v:
Surgery Today. 52:441-448
Lenvatinib (LEN) is a molecular-target drug, used for unresectable hepatocellular carcinoma (HCC). It is associated with adverse events (AEs), including hypertension, proteinuria, fatigue, and anorexia, which may force dose reduction or discontinuati
Publikováno v:
Advances in Therapy
Schizophrenia is characterized by positive, negative, cognitive, and affective symptoms. Antipsychotic medications, which work by blocking the dopamine D2 receptor, are the foundation of pharmacotherapy for schizophrenia to control positive symptoms.
Autor:
Naoyuki Uchida, Masahiro Abe, Shuichi Taniguchi, Hideki Araoka, Hideyuki Maruyama, Yoshihito Otsuka, Muneyoshi Kimura, Sho Ogura, Tomohisa Watari, Shinsuke Takagi
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 40:2095-2104
The aim of this study was to clarify the clinical and microbiological characteristics of Corynebacterium bacteremia in hematological patients. We retrospectively reviewed the medical records of patients with Corynebacterium bacteremia from April 2013
Publikováno v:
European Journal of Clinical Pharmacology. 77:1333-1339
Warfarin-associated coagulopathy commonly occurs in patients undergoing treatment with this anticoagulant. This trial aimed to determine the efficacy of using low-dose orally administered vitamin K1 to lower international normalized ratio (INR) value
Autor:
Moshe E. Gatt, Ofer Shpilberg, Noa Lavi, Eyal David, Adi Moshe, Shuang-Yin Wang, Irit Avivi, Chamutal Gur, Assaf Weiner, Baoguo Li, Oren Pasvolsky, Mor Zada, Shir Shlomi-Loubaton, Tamar Tadmor, Meirav Laiba, Chamutal Bornstein, Efrat Luttwak, Chezi Ganzel, Anatoly Nemets, Yael C Cohen, Ory Rouvio, Osnat Jarchowcky-Dolberg, Mouna Ballan, Najib Dally, Iuliana Vaxman, Olga Shvetz, Ido Amit, Evgeni Chubar
Publikováno v:
Nat Med
Multiple myeloma (MM) is a neoplastic plasma-cell disorder characterized by clonal proliferation of malignant plasma cells. Despite extensive research, disease heterogeneity within and between treatment-resistant patients is poorly characterized. In